European Medicines Agency’s data protection notice for the management of traineeships at EMA

Minutes of the CAT meeting 18-20 March 2026

Minutes of the COMP meeting 17-18 March 2026

Questions and answers on implementation of Ph.Eur. Medicinal Product Monographs (MPM)

Human medicines European public assessment report (EPAR): Onerji, levodopa,carbidopa, Date of authorisation: 27/04/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Ilaris, canakinumab, Date of authorisation: 23/10/2009, Revision: 35, Status: Authorised

QRD veterinary combined label-leaflet template v.9.1

Human medicines European public assessment report (EPAR): Mvabea, Ebola vaccine (MVA-BN-Filo [recombinant]), Date of authorisation: 01/07/2020, Revision: 7, Status: Withdrawn

Human medicines European public assessment report (EPAR): Zabdeno, ebola vaccine (Ad26.ZEBOV-GP [recombinant]), Date of authorisation: 01/07/2020, Revision: 10, Status: Withdrawn

Human medicines European public assessment report (EPAR): Qutenza, capsaicin, Date of authorisation: 15/05/2009, Revision: 21, Status: Authorised